Editors’ Picks: November Highlights from the AACR Journals
As the deep reds and yellows of fall leaves give way to twinkling holiday lights, we welcome the new...
As the deep reds and yellows of fall leaves give way to twinkling holiday lights, we welcome the new...
The AACR Annual Meeting 2023, held April 14-19, commemorated several milestones, including the 25th anniversary of the approval of...
by Ashok Venkitaraman, MBBS, PhD Singapore will hold its 15th Frontiers in Cancer Science (FCS) conference November 6-8 at...
AACR is a pioneer in the study of racial/ethnic and other disparities in cancer research and care. The 16th...
Centuries ago, when several Native tribes in northeastern America were at constant war, a peacemaker came to stop the...
In the beginning of his cancer journey, Edward Cutler felt unlucky. In 2012, he saw an ad suggesting that...
As the temperatures start to drop and the leaves begin to change color, enjoy the latest selection of studies...
As hundreds of cancer researchers and patient advocates traveled to Florida for the 16th AACR Conference on the Science...
Renowned prostate cancer researcher Folakemi T. Odedina, PhD, took the stage at the AACR Conference on the Science of...
FDA approvals issued in third quarter 2023 included a new treatment for prostate cancer harboring BRCA mutations, two new...
Based on estimates from the National Cancer Institute, in 2023, more than 110,000 cases of gynecologic cancers are expected...